Less Ads, More Data, More Tools Register for FREE

Pin to quick picksShire Share News (SHP)

  • There is currently no data for SHP

Friday broker round-up

Fri, 11th Nov 2016 09:55
(ShareCast News) - Imperial Brands: JP Morgan keeps at neutral with a target price of 3660p.Standard Life: Berenberg stays at buy 416p target.Barclays: Societe Generale upgrades to buy with a 235p target.UBM: Barlcays reiterates equal-weight with a 755p target.Derwent London: Goldman Sachs keeps at buy with a 3035p target.ITV: UBS reiterates neutral with a target price of 170p.Fevertree: Berenberg reiterates buy with a target price of 1200p.Shire: Goldman Sachs reiterates buy with a 6300p target.Aldermore: JP Morgan reiterates neutral with a 220p target.Prudential: Goldman Sachs reiterates buy with a target price of 1775p.Associated British Foods: Societe Generale upgrades to buy with a 3150p target.

Related News

UK considers forcing social media firms to prioritise trusted news
4 hours ago

UK considers forcing social media firms to prioritise trusted news

LONDON, June 22 (Reuters) - Britain is considering forcing social ​media companies ⁠to prioritise what the government ​called trusted news sources as ...

UK's FTSE 100 climbs on banks boost; markets ponder PM Starmer's resignation
9 hours ago

UK's FTSE 100 climbs on banks boost; markets ponder PM Starmer's resignation

* easyJet up after Castlelake discloses takeover interest

Shire News

UPDATE 1-Sumitomo Dainippon Pharma investing $3 bln in Swiss Roivant in overseas push
6 Sep 2019

UPDATE 1-Sumitomo Dainippon Pharma investing $3 bln in Swiss Roivant in overseas push

* Dainippon to buy 10% stake in Roivant and interests in 5 units * Schizophrenia treatment Latuda to lose US exclusivity in 2023 * Japan pharma firms ...

UPDATE 1-Germany's Stada 'very selective' on acquisitions - CEO Goldschmidt
14 Aug 2019

UPDATE 1-Germany's Stada 'very selective' on acquisitions - CEO Goldschmidt

FRANKFURT, Aug 14 (Reuters) - German generic drugmaker Stada will be careful about buying businesses and companies outright, and for now will focus ma...

Takeda kicks off sale of Western European drugs - sources
17 Jul 2019

Takeda kicks off sale of Western European drugs - sources

By Arno Schuetze and Pamela Barbaglia FRANKFURT/LONDON, July 17 (Reuters) - Japan's Takeda Pharmaceutical Co has reached out to prospective bidders fo...

Japan's Takeda expects binding offers for Latam business by end of May -sources
16 May 2019

Japan's Takeda expects binding offers for Latam business by end of May -sources

By Tatiana Bautzer SAO PAULO, May 16 (Reuters) - Japan's Takeda Pharmaceutical Co expects to receive binding offers for its Latin American business by...

Nikkei snaps 7-day losing streak helped by China's stimulus hopes
15 May 2019

Nikkei snaps 7-day losing streak helped by China's stimulus hopes

* Gains may be short-lived - analyst * Takeda Pharma, Nissan sink after earnings shock * Mitsubishi Estate jumps on share buyback, governance reform B...

Nikkei hobbled by trade worries, disappointing earnings
15 May 2019

Nikkei hobbled by trade worries, disappointing earnings

* Nikkei down slightly after 7 losing sessions * Uncertainties over U.S.-China standoff keep investors on edge * Takeda Pharma, Nissan sink after earn...

UPDATE 1-Japan's Takeda forecasts 193 bln yen annual operating loss on Shire deal
14 May 2019

UPDATE 1-Japan's Takeda forecasts 193 bln yen annual operating loss on Shire deal

* 193 bln Y op loss forecast this yr vs 227.5 bln profit view of analysts * Shire acquisition made Takeda one of the world's most indebted drugmakers ...

Japan's Takeda expects annual loss on Shire deal
14 May 2019

Japan's Takeda expects annual loss on Shire deal

TOKYO, May 14 (Reuters) - Takeda Pharmaceutical Co forecast on Tuesday it would have an operating loss in the current financial year, as it books cost...